Business context and reporting period
The filing is NorthWest Indiana Bancorp’s unaudited Form 10-Q for the quarter ended March 31, 2020, comparing operating results with the three months ended March 31, 2019 and financial position with December 31, 2019. The Bancorp is a bank holding company whose earnings are primarily dependent on Peoples Bank SB. The request metadata identifies Finward Bancorp; investors should verify the relationship between that name and the registrant named in this filing.
Key financial results
Dollar amounts are in millions unless stated otherwise.
| Metric | Q1 2020 / March 31, 2020 | Comparable / prior date |
|---|---|---|
| Net income | $3.192; diluted EPS $0.92 | Q1 2019: $2.222; diluted EPS $0.66 |
| Net interest income | $10.671 | Q1 2019: $10.600 |
| Provision for loan losses | $0.514 | Q1 2019: $0.317 |
| Noninterest income | $3.546 | Q1 2019: $2.570 |
| Noninterest expense | $9.999 | Q1 2019: $10.291 |
| Total assets | $1,349.9 | Dec. 31, 2019: $1,328.7 |
| Loans receivable, gross | $919.0 | Dec. 31, 2019: $906.9 |
| Deposits | $1,161.6 | Dec. 31, 2019: $1,154.4 |
| Cash and cash equivalents | $42.1 | Dec. 31, 2019: $47.3 |
| Stockholders’ equity | $140.7; 10.42% of assets | Dec. 31, 2019: $134.1 |
- ROA was 0.97% and ROE was 9.38%, versus 0.72% and 7.59%, respectively, in Q1 2019. The efficiency ratio improved to 70.3% from 78.1%.
- Net interest margin was 3.50% (3.62% tax-equivalent), versus 3.74% (3.81% tax-equivalent). Interest-rate spread fell to 3.47% from 3.71%.
- Operating cash flow was $9.5 million; investing cash flow was negative $22.3 million; financing cash flow was positive $7.7 million. Cash and equivalents declined $5.1 million during the quarter. Q1 2019 cash flows included $52.6 million of net cash from the AJSB acquisition, limiting direct comparison.
- Period-end borrowings comprised $14.0 million of borrowed funds and $13.0 million of repurchase agreements. Deposits funded 79.1% of gross loans. Management said on- and off-balance-sheet liquidity sources were sufficient for expected funding needs.
- Capital ratios remained above stated regulatory minimums. At March 31, Bancorp common equity Tier 1 and Tier 1 risk-based ratios were 12.0%, total capital was 13.0%, and Tier 1 leverage was 8.7%. The Bank was reported as well capitalized, with corresponding ratios of 11.8%, 11.8%, 12.8%, and 8.6%.
Material changes versus comparable periods
- Net income rose 43.7% year over year. Higher noninterest income and lower noninterest expense more than offset the higher loan-loss provision and modest net interest income growth.
- Noninterest income increased 38.0%, including higher loan-sale gains ($0.635 million versus $0.242 million), securities-sale gains ($0.510 million versus $0.352 million), and other income ($0.569 million versus $0.124 million). Management attributed much of the increase in other income to fair-value gains on interest-rate lock commitments.
- Noninterest expense decreased 2.8%. Lower other expense reflected the absence of prior-year AJSB acquisition costs; compensation and occupancy costs increased.
- From year-end, gross loans increased $12.1 million and deposits increased $7.3 million. Securities available-for-sale rose $16.2 million to $293.4 million, partly reflecting market-value gains; accumulated other comprehensive income increased to $8.7 million from $4.3 million.
- Credit indicators weakened modestly: nonperforming loans increased to $8.1 million, or 0.88% of loans, from $7.4 million, or 0.81%; substandard loans rose to $10.6 million from $8.1 million; and special-mention loans rose to $14.1 million from $12.6 million. The allowance increased to $9.5 million, or 1.03% of loans, from $9.0 million, or 0.99%; coverage of nonperforming loans declined to 117.8% from 122.1%.
Outlook, risks, contingencies and unusual items
- COVID-19: Management described substantial uncertainty from economic disruption, unemployment, and market volatility. It warned of possible weaker loan demand, delinquencies, defaults, collateral values, higher credit-loss provisions, reduced net interest margin and wealth-management revenue, and pressure on liquidity, earnings, and dividends. Management expected some further margin compression in the next two quarters, while noting that recovery could allow redeployment of excess liquidity. No quantified earnings or full-year guidance was provided.
- Borrower relief and PPP: As of May 4, 2020, after quarter-end, the Bank had approved 710 PPP applications totaling $90.3 million. At that date, reported payment modifications covered 74 mortgage loans totaling $8.5 million and 84 commercial loans totaling $42.8 million. These are subsequent-date figures, not March 31 balances. The Bank also reported 47 eligible SBA 7(a) loans with $6.5 million aggregate principal under the CARES Act subsidy program.
- Credit concentrations: Commercial real estate was 30.5% of loans. At March 31, restaurant, hotel, and non-owner-occupied retail loans were 8%, 6%, and 17% of the commercial real estate portfolio, respectively. Management disclosed weighted-average debt-service coverage ratios of 1.75, 1.24, and 1.45, and loan-to-value ratios of 49%, 54%, and 51%, respectively.
- Other items: Q1 included $0.510 million in net securities-sale gains and notable mortgage-sale activity. The company held $2.2 million cost basis of pooled trust preferred securities in payment-in-kind status; these securities had $1.424 million of gross unrealized losses at quarter-end, and management reported no additional impairment. Goodwill was $11.1 million; management warned that a sustained share-price decline or other triggering event could prompt impairment testing, but no goodwill impairment had been recorded.
- The Bancorp reported $194.1 million of outstanding loan-funding commitments, 54.5% at variable rates, and $11.4 million of standby letters of credit. Management believed available cash flow and borrowing capacity were sufficient to fund them. Ordinary-course legal proceedings were not expected by management to have a material adverse effect. Disclosure controls were deemed effective; no material change in internal control was reported.
Important facts for investors to verify
- Confirm the registrant identity and any connection to the Finward Bancorp name in the request metadata.
- Track the duration and extent of COVID-19 borrower relief, PPP balances and fees, and subsequent loan performance.
- Monitor delinquencies, nonperforming and classified loans, commercial real estate exposures, and the adequacy of the allowance as economic effects emerge.
- Assess whether lower rates and liquidity needs further compress net interest margin, and whether elevated noninterest income items recur.
- Review liquidity, deposit trends, capital ratios, dividend capacity, and potential credit or impairment effects from the trust preferred securities and goodwill.